Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
modified FOLFIRINOX regimen
DRUG
2 trials
Sponsors
Yonsei University
, Angiodynamics, Inc.
Conditions
Pancreatic Ductal Adenocarcinoma
Stage III Pancreatic Cancer
Phase 2
Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial
Completed
NCT02440958
Yonsei University
Pancreatic Ductal Adenocarcinoma
Start: 2015-08-28
End: 2017-03-02
Updated: 2019-02-18
Phase 3
A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer
Active, not recruiting
NCT03899636
Angiodynamics, Inc.
Stage III Pancreatic Cancer
Start: 2021-02-23
End: 2025-04-30
Target: 528
Updated: 2025-02-12
Related Papers
Multicenter randomized controlled trial and registry study to assess the safety and efficacy of the NanoKnife® system for the ablation of stage 3 pancreatic adenocarcinoma: overview of study protocols.
2021-07-07
10 citations